CATX
Price:
$3.24
Market Cap:
$218.98M
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is b...[Read more]
Industry
Medical - Devices
IPO Date
2005-11-10
Stock Exchange
NYSE
Ticker
CATX
According to Perspective Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -26.18%. This represents a change of 126.67% compared to the average of -11.55% of the last 4 quarters.
The mean historical ROE of Perspective Therapeutics, Inc. over the last ten years is -46.31%. The current -26.18% ROE has changed -43.47% with respect to the historical average. Over the past ten years (40 quarters), CATX's ROE was at its highest in in the March 2023 quarter at -0.31%. The ROE was at its lowest in in the June 2018 quarter at -46.88%.
Average
-46.31%
Median
-42.92%
Minimum
-133.20%
Maximum
-4.73%
Discovering the peaks and valleys of Perspective Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 146.81%
Maximum Annual ROE = -4.73%
Minimum Annual Increase = -91.72%
Minimum Annual ROE = -133.20%
Year | ROE | Change |
---|---|---|
2023 | -61.86% | 130.42% |
2022 | -26.85% | 129.99% |
2022 | -11.67% | 146.81% |
2021 | -4.73% | -91.72% |
2020 | -57.12% | -9.55% |
2019 | -63.15% | -52.59% |
2018 | -133.20% | 129.18% |
2017 | -58.12% | 102.35% |
2016 | -28.72% | 62.16% |
2015 | -17.71% | -28.80% |
The current ROE of Perspective Therapeutics, Inc. (CATX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-33.46%
5-year avg
-32.45%
10-year avg
-46.31%
Perspective Therapeutics, Inc.’s ROE is greater than OrthoPediatrics Corp. (-7.64%), greater than Orthofix Medical Inc. (-21.25%), greater than Sight Sciences, Inc. (-47.28%), greater than NeuroPace, Inc. (-205.41%), greater than CVRx, Inc. (-89.06%), greater than PAVmed Inc. (-48.30%), less than ProSomnus, Inc. (50.75%), greater than Hyperfine, Inc. (-57.54%), less than Electromed, Inc. (15.32%), greater than Surmodics, Inc. (-9.56%), greater than Paragon 28, Inc. (-38.77%), less than LivaNova PLC (1.88%), greater than Pulmonx Corporation (-53.88%), greater than SI-BONE, Inc. (-22.51%),
Company | ROE | Market cap |
---|---|---|
-7.64% | $556.24M | |
-21.25% | $674.86M | |
-47.28% | $181.19M | |
-205.41% | $330.42M | |
-89.06% | $323.31M | |
-48.30% | $7.08M | |
50.75% | $8.18M | |
-57.54% | $64.19M | |
15.32% | $251.04M | |
-9.56% | $565.90M | |
-38.77% | $863.99M | |
1.88% | $2.56B | |
-53.88% | $267.33M | |
-22.51% | $571.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Perspective Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Perspective Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Perspective Therapeutics, Inc.'s ROE?
How is the ROE calculated for Perspective Therapeutics, Inc. (CATX)?
What is the highest ROE for Perspective Therapeutics, Inc. (CATX)?
What is the 3-year average ROE for Perspective Therapeutics, Inc. (CATX)?
What is the 5-year average ROE for Perspective Therapeutics, Inc. (CATX)?
How does the current ROE for Perspective Therapeutics, Inc. (CATX) compare to its historical average?